Liquidia (NASDAQ:LQDA) Director Sells $2,758,807.11 in Stock

Liquidia Corporation (NASDAQ:LQDA) Director Katherine Rielly-Gauvin sold 36,789 shares of the business’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $74.99, for a total transaction of $2,758,807.11. Following the transaction, the director owned 44,637 shares in the company, valued at approximately $3,347,328.63. This represents a 45.18% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Katherine Rielly-Gauvin also recently made the following trade(s):

• On Thursday, August 20th, Katherine Rielly-Gauvin sold 18,393 shares of Liquidia stock. The stock was sold at an average price of $72.23, for a total transaction of $1,328,526.39.

Liquidia Stock Down 3.4%

LQDA traded down $2.43 during trading on Friday, reaching $68.62. 1,698,657 shares of the stock traded hands, compared to its average volume of 1,793,328. The stock’s 50-day simple moving average is $79.34 and its two-hundred day simple moving average is $56.13. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12. Liquidia Corporation has a fifty-two week low of $21.15 and a fifty-two week high of $93.61. The stock has a market cap of $6.14 billion, a price-to-earnings ratio of 50.09 and a beta of 0.58.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings results on Wednesday, August 12th. The company reported $0.74 EPS for the quarter, missing the consensus estimate of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The firm had revenue of $171.68 million during the quarter, compared to the consensus estimate of $168.48 million. During the same period in the previous year, the firm posted ($0.49) EPS. The company’s quarterly revenue was up 1842.1% compared to the same quarter last year. As a group, equities research analysts expect that Liquidia Corporation will post 2.57 EPS for the current year.

Analysts Set New Price Targets

LQDA has been the topic of several analyst reports. Lifesci Capital lowered shares of Liquidia from an “outperform” rating to a “hold” rating and set a $90.00 price target on the stock. in a research note on Wednesday, August 12th. Oppenheimer set a $75.00 price objective on shares of Liquidia in a research note on Friday, June 5th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $60.00 price objective on shares of Liquidia in a research note on Monday, May 11th. BTIG Research upped their price objective on shares of Liquidia from $109.00 to $111.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Finally, Zacks Research downgraded shares of Liquidia from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $98.08.

Institutional Trading of Liquidia

Large investors have recently modified their holdings of the company. GSA Capital Partners LLP grew its stake in Liquidia by 63.6% in the 4th quarter. GSA Capital Partners LLP now owns 63,176 shares of the company’s stock valued at $2,179,000 after buying an additional 24,555 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in Liquidia by 63.3% during the 1st quarter. The Manufacturers Life Insurance Company now owns 58,265 shares of the company’s stock worth $2,199,000 after acquiring an additional 22,592 shares during the last quarter. State of New Jersey Common Pension Fund D bought a new stake in Liquidia during the fourth quarter valued at about $709,000. WCG Wealth Advisors LLC boosted its holdings in Liquidia by 98.2% during the fourth quarter. WCG Wealth Advisors LLC now owns 54,411 shares of the company’s stock valued at $1,877,000 after acquiring an additional 26,957 shares during the period. Finally, Handelsbanken Fonder AB acquired a new stake in shares of Liquidia in the second quarter valued at about $1,993,000. 64.54% of the stock is owned by institutional investors.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).